Table 2.
Distribution of HARBOR study eyes across baseline MNV lesion types
| Baseline MNV lesion type, n (%) | Monthly treated eyes (n = 346) |
PRN-treated eyes (n = 354) |
Pooled study eyes (N = 700) |
|---|---|---|---|
| Type 1 | 123 (35.5) | 140 (39.5) | 263 (37.6) |
| Type 2/M | 151 (43.6) | 136 (38.4) | 287 (41.0) |
| Any type 3 | 72 (20.8) | 78 (22.0) | 150 (21.4) |
MNV macular neovascularization, PRN pro re nata (as-needed), type 2/M type 2/mixed type 1 and 2